Description: Session 2H: Reinsurance Market Update

Description: Attend this webcast to learn more on how to navigate managing ESG principles in the new normal of a post-COVID world. Enhance your ESG insights in a post-pandemic landscape.

Description: This session will provide an analysis of the latest activities and trends in asset-intensive reinsurance (AIR), including life, annuity, long-term care (LTC), and pension risk transfer (PRT) transactions, and their anticipated impact on the industry in the coming years. Speakers will delve into the strategic considerations of reinsurers, the concerns and preferences of insurers, and the perspectives of rating agencies. Through a case study, the session will demonstrate how asset-intensive reinsurance can serve as a capital lever and profitability enhancer within the evolving regulatory landscape. The discussion will highlight how these strategies support insurers' strategic initiatives, enhance internal rates of return (IRR) and other key performance indicators (KPI), facilitate sales growth and product launches, and improve the financial strength of the company. Additionally, as many of these transactions utilize alternative asset classes to enhance yields, the speakers will examine the differences among these asset classes and the key considerations when incorporating or modeling them in actuarial work.

Description: Cayman is a rapidly growing reinsurance domicile with several notable transactions executed in the past few years. We expect this trend to persist as (re)insurers will continue to explore more effective ways to manage their business. In this session, you will gain: - An overview of how the Cayman (re)insurance market has developed over recent years - An introduction to the Cayman regulatory framework - Key considerations for reinsurance structuring and pricing. Join a discussion at the close of the session on the outlook for the Cayman market. You will leave this session with an understanding of the Cayman (re)insurance market, the regulatory framework and key factors that impact reinsurance structuring and pricing.

Description: Dive into the vibrant world of Bermuda's reinsurance market! This session will provide a comprehensive overview of the latest market trends shaping Bermuda's dynamic landscape. First, we will discover how global shifts and regulatory changes are influencing market strategies and review recent deal activity. Afterward, we will explore hot topics in offshore valuation, exploring innovative approaches and methodologies that are emerging in this unique jurisdiction. Whether you're interested in market dynamics or valuation intricacies, this session promises to equip you with the insights needed to stay ahead in Bermuda's ever-evolving financial ecosystem. Join us for an informative journey that combines expert analysis with practical insights.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: This report examines the adoption and challenges of predictive analytics in life and annuity reinsurance, including current practices, regulatory context, and advanced AI applications.

Description: Canada has been proactive in establishing governance frameworks for reinsurance transactions. Initiatives from individuals, the Office of the Superintendent of Financial Institutions OSFI and the Canadian Institute of Actuaries CIA have addressed concerns about and scrutiny of reinsurance transactions from worldwide securities and insurance regulators, rating agencies and the media. It is important to note that actuaries have played a vital role in identifying and developing these initiatives and will continue to have a major influence in further development of governance standards and in providing education. From The Actuary Magazine June 2007

Description: The article also discusses the lasting impact of COVID-19 on public health, including excess mortality and the emergence of long COVID as a significant cause of disability. It emphasizes the importance of robust product definitions and regulatory intervention in the insurance industry, as well as addressing the protection gap. The author concludes by reflecting on the resilience and compassion shown during the pandemic and the pressing issue of climate change, which presents both challenges and opportunities for innovation in the insurance sector.

Description: This session will look into life insurers’ anticipated business impacts as a result of the implementation of the new accounting standard for insurance contracts, IFRS 17. What will be the financial impact as of day one as a result of transition? How will embedded value for common life insurance products change? How will costs of reinsurance be affected? Will products have to be re-designed and/or re-priced? IFRS 17 may have more ramifications into the way insurers are doing business than we have anticipated so far. While we are working on the implementation of this new standard, we should not lose sight of the business impacts that will follow. At the conclusion of the session, attendees will be able to: Understand key impacts of the transition to IFRS 17; See illustrative examples of the impact on embedded value; and Understand key impacts on product design and pricing Country Relevance: US and Canada